Overview

Ezetrol Post-Marketing Study

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare the lipid lowering efficacy of adding ezetimibe to statin vs. statin alone.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe
Simvastatin